Among them is administration of depot injections which slowly releases the drug and maintains the appropriate blood levels.

A single depot injection of an antipsychotic drug can be effective for as long as four weeks.

It is available as an intramuscular depot injection.

Depot injections are usually either solid or oil-based.

Prostate cancer patients receiving hormone therapy usually get depot injections as a treatment or therapy.

Depot injections may be available as certain forms of a drug, such as decanoate salts or esters.

Examples of depot injections include Depo Provera and haloperidol decanoate.

Overdoses with depot injections are uncommon, because only certified personnel are legally permitted to administer them to patients.

The antipsychotic agent Benperidol is also indicated for this purpose, and can also be given by depot injection as a means of increasing compliance.

It is an aqueous suspension for depot injection of the pregnane 17α-hydroxyprogesterone-derivative progestin medroxyprogesterone acetate.

Long-acting forms of subcutaneous/intramuscular injections are available for various drugs, and are called depot injections.

Androgen replacement is administered by patch, tablet, pill, cream or gel; or depot injections given into fat or muscle.

Risperidone is available as a tablet, an oral solution, and an ampule, Risperdal Consta, which is a depot injection administered once every two weeks.

Psychiatrists rarely visited younger patients at home unless a compulsory admission appeared necessary, but community psychiatric nurses were in close touch, often through their administration of regular depot injections.

Paliperidone (Invega) - Derivative of risperidone that was approved in 2006, it offers a controlled release once-daily dose, or a once-monthly depot injection.

The advantages of using a long-acting depot injection include increased Compliance (medicine) due to reduction in the frequency of dosing, as well as more consistent serum concentrations.

Depot injections can also be used for involuntary community treatment patients to ensure compliance with a community treatment order when the patient would refuse to take daily oral medication.

A depot injection is an injection, usually subcutaneous or intramuscular, of a pharmacological agent which releases its active compound in a consistent way over a long period of time.

Since distribution of a drug from fatty tissue is usually slow, one may develop a long-acting injectable form of a drug (called a Depot injection) by using its decanoate form.

Under the Mental Health Act 1959 patients maintained on guardianship orders knew that drug treatment could be enforced and therefore appeared regularly for depot injection on the right day and at the right time without pressure or demur.

DepoDur CII, previously known as DepoMorphine, is a morphine sulfate extended-release liposome injection (see Depot injection), product of Pacira Pharmaceuticals (formerly SkyePharma PLC).

Lupron Depot (7.5 mg/vial for monthly intramuscular depot injection) was first approved by the FDA for palliative treatment of advanced prostate cancer on January 26, 1989, and subsequently in 22.5 mg/vial and 30 mg/vial for intramuscular depot injection every 3 and 4 months, respectively.